Specialties & Topics
- Arthritis/Rheumatic Disease
- Breast Cancer
- GERD/Peptic Ulcers
Join us for ongoing discussions with our physician-editors,
An ongoing dialogue on HIV/AIDS, infectious diseases,
all matters medical, and some not so medical.
Five ID/HIV Things to be Grateful for this Holiday Season, 2014 Edition • November 24, 2014
Amidst outbreak hysterias, anti-vaccine imbecility, electronic medical record whining, and slug-related eosinophilia, I bring you this year’s version of the good news — the 2014 edition of Five ID/HIV Things to be Grateful for this Holiday Season, just in time for your holiday turkeys. (Needless to say, the bird will be properly cooked to ensure it’s salmonella-free, with all […]
Notes from chief residents in family and internal medicine.
Introducing Myself • October 6, 2014
Hello! I’m excited to have an opportunity to share my adventures, experiences, and opinions from chief year with you. Transitioning between life phases can be traumatic at times, but invariably bears great potential for exponential self–growth. This year, so far, has confirmed that there is indeed much growing to be done! We held a transition event […]
An insider's notes on the practice.
Clip, Burn, Inject, or All Three? How Do You Treat Ulcer Bleeding? • October 23, 2014
As endoscopists, we have all sorts of tools to treat ulcer bleeding or other gastrointestinal bleeding, such as injection with epinephrine and thermal coaptive coagulation with heater probes or multipolar electrodes like the Gold probe. More recently, a myriad of clips have become available for use. It seems to me that both operator and ulcer […]
Audio podcasts featuring the week's news,
plus your comments and pertinent interviews.
Podcast 174: PARADIGM and heart failure • September 10, 2014
The PARADIGM-HF trial of LCZ696 — a novel compound that both blocks the renin-angiotensin system with an ARB component and blocks neprilysin’s degradation of natriuretic peptides — increased survival in heart failure by some 20% relative to enalapril. It seems to be a big deal, and the trial’s two principal authors have agreed to talk […]